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Purpose: An endothelialized lumen within a synthetic graft that expresses recombinant 
proteins with anticoagulant orantiproliferative activity has the potential to improve graft 
function. However, preliminary data suggest that genetic modification of endothelial cells 
(ECs) impairs their proliferation. The purpose of this investigation was to test the 
hypothesis that retroviral transduction of cultured ECs with the lac Z gene encoding for 
13-galactosidase would decrease EC proliferation in vitro and graft endothelialization 
in vivo. 
Methods: In vitro studies compared canine EC proliferation over a 14-day period among 
early-passage ECs (two and three) and late-passage ECs (six and nine) transduced with the 
BAG vector (containing the lac Zgene and the neomycin resistance gene), ECs transduced 
with the neomycin resistance gene only, and nontransduced ECs. In vivo canine studies 
assessed endothelialization f expanded polytetrafluoroethylene thoracoabdominal grafts 
seeded with autologous lac Z-transduced ECs (n = 7) or nontransduced ECs (n-= 3) 
compared with that of nonseeded grafts (n = 3). Histochemical staining and DNA 
polymerase chain reaction was used 6 weeks after implantation todetect the presence of the 
lac Z gene in the grafts' cellular linings and perigraft issues. Endothelialization was 
assessed by light microscopy and electron microscopy. 
Results: Proliferation of late-passage lac Z-transduced ECs in vitro was significantly 
decreased compared with neomycin resistance-transduced ECs or nontransduced ECs. 
Among early-passage ECs smaller but significant decreases in proliferation were noted 
among lac Z-transduced cells compared with nontransduced cells. Six of seven expanded 
polytetrafluoroethylene grafts seeded with transduced ECs showed lac Z gene expression. 
Lac Z gene expression was not found on grafts seeded with nontransduced ECs or 
nonseeded grafts. The endothelialized luminal surface area was significantly ess in grafts 
seeded with lac Z-transduced ECs compared with grafts seeded with nontransduced ECs. 
Conclusions: Retroviral-mediated ransduction ofcanine ECs with the lac Z gene encoding 
for [~-galactosidase impairs EC proliferation i vitro and the ability of transduced ECs to 
form a confluent EC monolayer on the luminal surface of synthetic grafts in vivo. (J Vase 
Surg 1996;24:892-9.) 
Despite substantial experience with synthetic vas- 
cular grafts, none has been found suitable for replace- 
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ment of small arteries. Autologous endothelial cell 
(EC) seeding of small-caliber synthetic vascular grafts 
in most animal studies promotes rapid surface endo- 
thelialization, improves graft patency, and normalizes 
platelet survival at earlier times. >3 However, clinical 
studies in humans uggest that EC seeding alone may 
not improve graft patency placed. 4-6 Nevertheless 
genetic modification of ECs seeded onto synthetic 
vascular grafts may improve graft function. Recombi- 
nant protein secretion by such ECs could reduce graft 
surface thrombogenicity, limit the development of 
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anastomotic ntimal hyperplasia, and thus increase 
long-term graft patency. 
Previous in vitro studies have confirmed that 
retroviral-mediated gene transfer and expression in 
ECs is feasible. 7-9 Similarly, in vivo experiments have 
shown that ECs transduced with a marker gene can 
be implanted and then recovered at short intervals 
after implantation) °-12 However, preliminary experi- 
ments from our laboratory and others suggest that 
retroviral transduction may impair EC prolifera- 
tion. 11J3,14 Decreased EC proliferation may lower 
the total recombinant protein production of a popu- 
lation of genetically modified ECs and thus compro- 
mise the effectiveness of this form of gene therapy. 
The purpose of this investigation was to test the 
hypothesis that retroviral lac Z-transduced ECs ex- 
pressing 15-galactosidase would exhibit decreased cel- 
lular proliferation i vitro and graft endothelialization 
in vivo. 
MATERIAL AND METHODS 
Endothelial cell derivation and characteriza- 
tion. Autologous canine ECs were enzymatically 
derived for these xperiments. In brief, external jugu- 
lar vein segments were excised from adult dogs and 
everted over a sterile rod. They were subsequently 
incubated in dispase (15 U/ml, Boehringer-Mann- 
helm, Indianapolis, Ind.), and the ECs were removed 
from the veins by spinning the rod at high speed in 
culture medium (M199 with EC growth supplement 
[ECGS, 25 gg/ml; Collaborative Biomedical Prod- 
ucts, Bedford, Mass.], heparin [15 g/ml] glutamine, 
penicillin/streptomycin [(500 U/ml/500 gg/ml], 
and 10% bovine plasma-derived serum). The ECs 
were cultured in a standard manner. The medium was 
changed every 2 to 3 days, and confluent EC cul- 
tures were subcultured every 7 to 10 days. ECs were 
confirmed by their appearance and by their low- 
density lipoprotein receptor uptake of the fluorescent 
ligand 1,1, - dioctadecyl - 3,3,31,3 - tetramethylindo- 
carbacyanine perchlorate (diI-Ac-LDL; Biomedical 
Technologies, Stoughton, Mass.). 
Retroviral transduction procedures. A murine 
amphotrophic retroviral vector BAG containing the 
bacterial ac Z gene encoding for 13-galactosidase 
(~-gal) and tile neomycin resistance gene was used to 
transduce the ECs. is Subconfluent ECs in log phase 
growth were exposed to retroviral supernatant for 12 
hours daily on 3 consecutive days in the presence of 
polybrene (8 gg/ml). Retroviral transduction was 
confirmed by cytochemical staining for 2 hours at 
37 ° C with a solution containing the substrate 
5-bromo-4-chloro-3-indoyl-[3-D-galactopyranoside 
(X-gal), which is cleaved by 15-galactosidase to yield a 
blue color. Initial transduction rates were approxi- 
mately 30% by X-gal staining. Transduced ECs were 
then placed in medium containing 1 mg/ml of the 
cytotoxic neomycin analog, G418, for 7 to 10 days. 
Repeat X-gal staining confirmed that virtually all of 
the G418-selected cells coexpressed [3-galactosidase. 
Identical retroviral exposure and selection procedures 
werc used to transduce a second group of ECs for the 
proliferation studies with the same amphotrophic 
retroviral construct, except that it contained only the 
neomycin resistance gene and not the lac Z gene. 
These cells were used to control for effects that might 
be attributed to the neomycin resistance gene and the 
selection process. 
Endothelial cell proliferation studies. Con- 
fluent parallel cultures of lac Z-transduced ECs, 
neomycin resistance-transduced ECs,and nontrans- 
duced ECs at early and late passages were plated on 
gelatin-coated six-well plates at a density of 2.0 × 103 
cells/cm 2.Medium changes were performed initially 
at 24 hours and every 48 hours thereafter. EC 
numbers were determined by cell detachment with 
trypsin and counting in a particle counter (Coulter 
Electronics, Hialeah, Fla.) at 1, 3, 5, 7, 9, and 14 days 
after plating (six wells each time). In two experiments 
parallel cultures were examined at early passages 
(passage two and three). In two subsequent experi- 
ments parallel cultures were examined at later pas- 
sages (passage six and nine). These experiments u ed 
cell lines derived from three different animals. The 
same cell line was tested at passages three and nine. 
Different cell lines were used for the passage two and 
six growth kinetics experiments. The ECs were trans- 
duced and selected in G418 one passage before each 
experiment was plated. X-gal staining confirmed vir- 
tually all lac Z-transduced ECs to be expressing 
[3-galactosidase before plating and at day 14 of each 
experiment. Cell numbers for the groups were com- 
pared with analysis of variance (ANOVA, Scheffe's 
test). 
Endothelial cell seeding of thoracoabdominal 
synthetic grafts. Conditioned adult male dogs (15 to 
20 kg) underwent placement of thoracoabdominal 
expanded polytetrafluoroethylene (ePTFE) aortic 
grafts with techniques previously reported from our 
laboratory. 16Transduced autologous ECs at cell pas- 
sages two to four (n = 3) and at passages six to nine 
(n = 4) and nontransduced ECs at passage 4 (n = 3) 
were seeded at a density of 5 x 104 cells/cm 2 on 10 
mm diameter x 30 cm microporous expanded poly- 
tetrafluoroethylene grafts with internodal distances of 
21 gm and a porosity of 0.32 mm (W.L. Gore and 
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Fig. 1. Proliferation of transduced and nontransduced 
ECs. Proliferation of late-passage ECs was less than that 
of early-passage ECs at all times (*p< 0.05, ANOVA, 
Scheffe's test), except late-passage nontransduced ECs 
achieved similar confluent densities as early-passage ECs 
by 14 days. Among early-passage ECs proliferation of 
lac Z-transduced ECs was significantly ess at days 3 and 5 
( * *p < 0.05, ANOVA). Among late-passage c lls prolifera- 
tion of lac Z-transduced ECs was significantly less than 
neomycin resistance-transduced ECs and nontransduced 
ECs at days 3, 5, and 9 (***p < 0.05, ANOVA). 
Associates, Flagstaff, Ariz.) precoated with autolo- 
gous nonheparinized whole blood. Seeded grafts 
were incubated at room temperature for 1 hour 
before implantation. After systemic heparinization 
was performed, the seeded graft was anastomosed 
end-to-side to the infrarenal aorta, tunneled through 
the posterior diaphragm, and then anastomosed nd- 
to-end to the proximal descending thoracic aorta. 
The distal descending thoracic aorta was then over- 
sewn. The end-to-side anastomosis to the infra- 
renal aorta pcrmitted retrograde perfusion of the 
proximal abdominal aorta, its visceral branches, and 
thc dcsccnding thoracic aorta. Nonseedcd ePTFE 
grafts (n = 3) were implanted in a similar manner and 
served as the control group. The grafts were retrieved 
for study 6 wceks latcr, being pcrfused in situ with 
balanced salt solution at physiologic pressure before 
undergoing sterile excision. All experiments con- 
formed to animal care and biosafety level 2 contain- 
ment guidelines of the National Institutes of Health, 
the Centers for Disease Control, and the University of 
Michigan Unit for Laboratory Medicine. 
Analyses of  seeded synthetic grafts for lac Z 
gene transfer and [3-galactosidase expression. 
Grafts were analyzed for lac Z gene transfer and 
13-galactosidase expression by several techniques: (1) 
At graft removal surface cells were immediately col- 
lected from the lumen of a small midgraft segment of 
each prosthesis after a 15-minute incubation in dis- 
pase. These cells were cultivated ex vivo. [3-galactosi- 
dase expression was ascertained by X-gal staining of 
these primary cultures when they reached confluence. 
(2) The remaining intact grafts were stained irectly 
en face with X-gal. (3) Graft surface cell DNA analysis 
also was accomplished with the polymerase chain 
reaction (PCR) to confirm the presence of the lac Z 
gene. For this procedure 25 base oligonucleotide 
primers were made to span a 388 base pair region 
within the coding sequence of the lac ZcDNA. Sense 
and antisense sequences were 5'-CGGCGAGT- 
TGCGTGACTACCTACGG-3' and 5'-GGATATC- 
CTGCACCATCGTCTGCTC-3', respectively. Ex- 
planted grafts previously examined under a micro- 
scope and mapped for regions of X-gal staining (see 
following text) were cut into I cm segments. Surface 
cells scraped from these segments were washed twice, 
pelleted at 1000g in a microcentrifuge, and resus- 
pended in 1× TE buffer (10 mmol /L  Tris, 1 mmol /L  
ethylenediaminetetraacetic acid, pH 8.0). One micro- 
liter of the cell suspension was added to 20 btl of Gene 
Releaser (BioVentures, Murfreesburo, Tenn.) and 
heated in a 700 W microwave oven at maximal setting 
for several minutes. A 1 btl aliquot of this mixture was 
then added to 50 btl of a PCR amplification solution 
containing 250 ng of each primer and 1.6 U Taq 
polymerase (Perldn Elmer Cetus, Norwalk, Conn.) in 
a PCR Optimizer buffer (InVitrogen, San Diego, 
Calif.) containing 30 mmol /L  Tris, 7.3 mmol /L  
ammonium sulfate, 1.75 mmol /L  MgC12, pH. 8.5. 
After this mixture was heated to 80 ° C, 8 ~tl of 10 
mmol /L  dNTP with a 50 btl mineral oil overlay was 
added to initiate reaction. After a 2-minute 94 ° C 
initial denaturation 35 cycles of 94 ° C denaturation 
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Table I. Verification of in vivo lac Zgene transfer and 13-galactosidase expression 
Assessment technique 
Direct en face X-gal stain of X-gal stain of EC cultured 
Graft type graft surface from graft explants 
PCR of graft 
surface cells 
Early-passage transduced EC 3 (3) 2 (3) 3 (3) 
Late-passage transduced EC 3 (4) 3 (4) 3 (4) 
Nontransduced EC 0 (3) 0 (3) 0 (3) 
Nonseeded 0 (3) 0 (3) 0 (3) 
Data presented as number of positive grafts (number of grafts examined). 
for 1 minute, 55 ° C annealing for 2 minutes, and 
72 ° C extension for 3 minutes were followed by a 
7-minute 72 ° C incubation. PCR products were 
analyzed by electrophoresis on 1% agarose gels 
stained with ethidium bromide. 
Analyses of synthetic grafts for surface ndo- 
thelialization. One half of" each excised graft was 
subjected to X-gal staining and high-power micros- 
copy to confirm EC staining. Areas of blue-stained 
ECs were mapped from photographs of the graft 
surfaces. Computer-assisted morphometry with im- 
age analysis oftware was used to quantitate he areas 
ofl3-galactosidase-expressing ECs as a percent of total 
graft surface area. Each half-graft was then divided 
into 1-cm 2 subsegmcnts and prepared for scanning 
electron microscopy. All subsegments were examined 
by scanning electron microscopy to provide an accu- 
rate assessment of total EC coverage including that 
attributed to[3-galactosidase-expressing ECs and that 
considered to be the result of native EC ingrowth. 
Again, areas of EC coverage were mapped from 
photographs ofthe scanned subsegments, and com- 
puter-assisted image analysis was used to quantitate 
the areas of coverage. Thus it was possible with these 
data to calculate the percent of total graft surface that 
underwent endothelialization and the percent of total 
graft surface bearing [3-galactosidase-expressing ECs. 
Differences in percent surface endothelialization 
among groups were compared (ANOVA, Scheffe's 
test). 
RESULTS 
In vitro endothelial cell proliferation studies. 
EC numbers at day 1 were similar among all groups, 
suggesting no apparent differences in immediate 
postplating cell viability. EC proliferation was calcu- 
lated as the fold increase in cell number over day 1 
baseline cell counts (Fig. 1). Proliferation of late- 
passage ECs was significantly decreased at all times 
compared with that of early-passage ECs. However, 
late-passage ECs achieved a similar confluent density 
as early passage ECS by day 14. Among early-passage 
ECs proliferation rates were slightly lower for 
lac Z-transduced ECs compared with those for con- 
trol ECs. However, significant decreases inprolifera- 
tion were noted only at days 3 and 5 for early-passagc 
lac Z-transduced ECs compared with early-passage 
control ECs (Fig. 1, upper panel). Among late- 
passage cells lac Z-transduced ECs demonstrated 
marked reductions in proliferation compared with 
nontransduced ECs and neomycin resistance-trans- 
duced ECs (Fig. 1, lowerpand). 
Analyses of seeded synthetic grafts for lac Z 
gene transfer and [3-galactosidase expression 
(Table I). Direct graft staining with X-gal demon- 
strated [~-galactosidase expression in six of seven 
transduced seeded grafts: three of three seeded with 
early passage ECs and three of four seeded with late 
passage ECs. ~-galactosidase expression was not ob- 
served on grafts eeded with nontransduced cells or in 
nonseeded grafts. 
Cells derived from luminal Surfaces of the seeded 
grafts were predominantly ECs. Mixed cell popula- 
tions composed of predominantly fibroblasts and 
smooth muscle-like cells with few ECs were derived 
from nonseeded control grafts. Among the grafts 
seeded with transduced ECs, cultivated ECs demon- 
strated [3-galactosidase expression from five of seven 
grafts: two of three early-passage rafts and three of 
four late-passage rafts. Cells derived from surfaces of 
grafts seeded with nontransduced ECs or nonseeded 
grafts did not exhibit X-gal staining. 
DNA PCR of cellular tissue removed from the 
surface of grafts seeded with transduced ECs demon- 
strated the presence of the expected lac Z gene 
sequence in six of seven grafts. No lac Z gene 
sequences were found in scrapings from the surface of 
grafts seeded with nontransduced ECs or in non- 
seeded grafts. 
Analyses of seeded synthetic grafts for surface 
endothelialization. X-gal staining of grafts 6 weeks 
after implantation revealed clear differences among 
graft types (Fig. 2). Among grafts seeded with lae 
Z-transduced ECs distinct areas of blue-stained cells 
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Fig. 2. Enface X-gal-stained graft surfaces (x8). Panel on 
right shows region ofl3-galactosidase-expressing ECs from 
lac Z-transduced EC seeded graft. Among transduced 
seeded grafts such foci of blue-stained ECs were distributed 
throughout surface of graft. Panel on left shows nontrans- 
duced EC seeded graft surface without evidence of X-gal 
13-galactosidase cellular staining. 
Hg. 3. Cross-sections ofgrafts (presented in Fig. 2) after 
X-gal staining for 13-galactosidase nd counterstaining with 
hematoxylin-eosin (x120). Blue-stained EC monolayer is
evident on surface of lac. Z-transduced EC seeded graft 
(right panel). No blue staining is seen on nontransduced 
EC seeded graft (left). 
were distributed across the surface. Graft seedcd with 
nontransduced EC surfaces and nonseeded grafts 
exhibited no cellular blue staining. Similarly, light 
microscopy of grafts seeded with lac Z-transduced 
ECs documented blue-stained monolayers on the 
luminal surface but no blue-stained cells present in 
grafts seeded with nontransduced ECs or nonseeded 
grafts (Fig. 3). 
Analyses of the extent of graft surface ndothelial- 
ization revealed significant differences among graft 
types both in regard to the total graft surface area that 
underwent cndothclialization a d the graft surface 
area covered by [3-galactosidase-expressing ECs (Fig. 
4). Total graft surface endothelialization i  non- 
seeded grafts considered to be caused by spontaneous 
ingrowth of native endothelium was documented to
be 31%. Grafts seeded with nontransduced ECs 
achieved 79% luminal endothelialization, consistent 
with coverage observed in previous studies.~6 Among 
grafts seeded with early-passage lac Z-transduced 
ECs, 28% of the graft lumen was endothelialized, and 
among grafts seeded with late-passage lac Z-trans- 
duced ECs, 42% of the graft lumen was endothelial- 
ized. Thus grafts seeded with lac Z-transduced ECs 
exhibited significantly less endothelialization than 
those seeded with nontransduced ECs. Furthermore 
less than half of the areas of grafts seeded with lac 
Z-transduced ECs cndothclializcd represented [3-ga- 
lactosidase-expressing ECs. In an additional analysis 
multiple samples ofnonblue-staining endothelialized 
areas from several grafts eeded with lac Z-transduced 
ECs were examined with DNA PCR technique 
(Fig. 5) and confirmed the absence of/ac ZDNA in 
the nonstained areas. 
DISCUSSION 
Genetic modification of the blood vessel wall 
represents a potentially important new approach for 
the treatment of vascular disease. One use for this 
technology is the development of genetically modi- 
fied EC-lined small-caliber vascular prostheses. How- 
ever, preliminary studies from our laboratory sug- 
gested that lac Z-transduced ECs proliferate at a 
slower rate compared with nontransduced ECs. 13'14 
It is possible that the reduced proliferation of 
lac Z-transduced ECs might be partly related to the 
late passage of the cells. Previous work by Mueller et 
al.17 with a cloned strain of bovine fetal aortic ECs 
exhibited a decline in EC proliferation as the cell 
passage number increased. These investigators also 
demonstrated that as the proliferation rates declined, 
the size and number of chromosomal bnormalities 
increased. Such aberrations could be increased by 
retroviral transduction of ECs. Although retroviral 
vectors transfer genes efficiently into a wide variety of 
mammalian cells and permit relatively stable long- 
term phenotypic modification, both genetic and epi- 
genetic events may lead to integration and expression 
in some cells that may bc transient or unstable. These 
observations raise a concern that transduction with 
certain retroviral vectors may be increasingly detri- 
mental to in vivo EC proliferation and survival with 
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Fig. 4. Mean percent total graft surface ndothelialization foreach graft ype and mean percent 
of graft surface area that demonstrated ECs with I]-galactosidase expression. Spontaneous 
coverage by ingrowth of native ndothelium was documented in nonseeded grafts at 31%. Among 
three groups of EC seeded grafts, nontransduced ECs achieved 79% coverage, significantly 
greater than all other graft types (*p < 0.05, ANOVA, Scheffe's test). Lac Z-transduced EC 
seeded grafts are divided into two groups for analysis: those grafts eeded with early-passage ECs 
(passage 2 to 4) achieved 28% total surface EC coverage, and those seeded with late-passage ECs 
(passage 6 to 9) achieved 42% total surface EC coverage. Less than halfofendothelialized areas 
in grafts eeded with lac Z-transduced ECs were covered by 13-galactosidase expressing ECs. 
increasing cell passage. Lending credence to this 
concern are our studies that demonstrated signifi- 
cantly decreased proliferation of late-passage ECs 
compared with early-passage ECs at each time point 
examined. Decreased proliferation was most marked 
among lac Z-transduced late-passage ECs. However, 
small yet statistically significant differences occurred 
in proliferation during log phase growth among 
early-passage lac Z-transduced ECs compared with 
nontransduced ECs. Based on our in vitro observa- 
tions we anticipated limited in vivo graft endothelial- 
ization with seeding of late-passage lac Z-transduced 
ECs, but we erroneously assumed that endothelial- 
ization with early-passage lac Z-transduced cells 
would be mimimally affected. 
The Escherichia coli lac Z gcne has been estab- 
lished to be useful in gene transfer experiments in
vitro as a means to genetically mark cells. ~4,~8 In fact, 
Dichek et al.7 suggested that lac Z-transduced ECs 
subjected to X-gal staining may be a simple and 
reliable means to verify and quantitate gene transfer in 
vivo as well. Such may not be the case. Despite the 
performance ofmeticulous X-gal staining technique, 
we frequently found areas of diffuse, light blue, 
granular staining on both grafts seeded with non- 
transduced ECs and on nonseeded grafts (Fig. 6). 
These findings are consistent with Dannenberg and 
Suga's is description of cross-staining ofthe ferrocya- 
nide component of the X-gal solution and cellular 
iron (Fe3+). Furthermore specific cell types such as 
macrophages and fibroblasts are known to be sources 
of positive X-gal staining. The potential for false- 
positive EC staining may require additional scrutiny 
of all stained surfaces. We verified the lac Z gene's 
presence under a high-power dissecting microscope, 
with scanning electron microscopy, and with PC1L It 
is important to recognize that the use of [3-galactosi- 
dase as an in vivo marker of lac Z gene transfer and 
expression is feasible but requires stringent assess- 
ment at the microscopic and molecular levels to verify 
such transfer and expression. 
Seeding of lac Z-transduced ECs in vivo on 
synthetic grafts in this investigation produced signifi- 
cantly less total graft surface ndothelialization than 
seeding with nontransduced ECs. Furthermore l ss 
than half of the endothelialized areas of graft seeded 
with lac Z-transduced ECs expressed the lac Z gene. 
Two explanations might account for why a significant 
fraction of the areas endothelialized did not exhibit 
13-galactosidase expression. First, lac Z-transduced 
ECs may have a limited life span or reduced prolifera- 
tion in vivo, and the nonexpressing areas might then 
JOURNAL OF VASCULAR SURGERY 
898 Baer et al. November 1996 
#14-20 
#17-18 
#18-12 
HMW 
Control EC 
#18-7 
(positive x-gal stained area) 
Plasmid 
Hg. 5. Representative gel after DNA PCR of sampled 
luminal cellular surface material from endothelialized areas 
of three lac Z-transduced EC seeded grafts that did not 
exhibit lac Z gene expression by X-gal staining. No lac Z 
DNA is present in graft specimens 14-20, 17-18, and
18-12, in contrast with expected lac Z EC DNA from 
positive X-gal staining re ion of graft specimen 18-7. 
simply represent coverage by native ECs. Second, the 
noncxpressing areas might represent transduced cells 
that subsequently failed to express the lac Zgene after 
seeding and graft implantation. The latter explanation 
is unlikely, because DNA PCRon multiple samples of 
non-X-gal staining endothelialized areas from grafts 
seeded with lac Z-transduced ECs confirmed the 
absence of lacZDNA. Although endothelializati0n of 
grafts eeded with lac Z-transduced ECs was greater in 
the early cell passage group compared with the late 
cell passage group, the difference in EC surface 
coverage (14.3% vs 5.2%) among these small numbers 
of experimental nimals did not reach statistical sig- 
nificance. Most important, in neither case did these 
low rates ofendothelialization approach the expected 
level of graft surface ndothelialization observed with 
nontransduced ECs. 
Although genetic modification of the arterial wall 
has been accomplished in several animal models in 
vivo, 1°'21"2a application of this technology to vascular 
prostheses has been limited to a few studies. 11'12'14 
Hg. 6. Nonspecific blue staining with X-gal reagent (x8). 
In panel on left, region from nontransduced EC seeded 
graft that was stained with appropriate technique reveals 
pattern of noncellular light blue staining. Panel on right 
represents segment ofnontransduced EC seeded graft that 
was purposely overstained. These examples demonstrate 
potential for e ror when relying on blue-stained appearance 
alone as evidence of lac Zgene expression. 
In experiments similar to ours Wilson et al. 12 docu- 
mented the presence of [3-galactosidase-expressing 
ECs on Dacron prosthetic grafts examined for up to 5 
weeks after implantation, although the extent of graft 
endothelialization was not assessed. 
Data from this investigation support the hy- 
pothesis that EC transduction with the lac Zgene may 
impair the genetically modified cell's ability to prolif- 
erate on a synthetic graft surface in vivo. The mecha- 
nism by which this transduction impedes cell prolif- 
eration is unknown. These effects may be specific to 
the lac Z gene and the BAG retroviral vector or may 
apply to other recombinant retroviruses. In this 
regard the addition of a third in vivo control group, 
grafts seeded with neomycin-resistance ECs, could 
have been useful in delineating a specific lac Z gene 
effect on endothelialization. However, Sackman et 
al.la noted that seeding Dacron and expanded poly- 
tetrafluoroethylene grafts placed in dogs with ECs 
transduced with four different retroviral vectors di- 
minished their ability to stably adhere and populate 
the graft's luminal surface. 11 Other effects not tested 
in this investigation may be responsible for the limited 
endothelialization by transduced cells such as impair- 
ment of EC graft adherence or EC migration under 
conditions of physiologic flow. In this regard Jalditsh 
et al. 2° have reported no alterations in the in vitro 
transduced EC phenotype with a different retroviral 
construct containing thehuman tissue plasminogen 
activator cDNA. However, Huber et al. 24 demon- 
strated decreased in vivo adherence of autologous 
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ECs transduced with another tissue plasminogen 
activator-expressing retroviral vector that were seeded 
onto expanded polytetrafluoroethylene carotid and 
iliac artery interposition grafts implanted in dogs. 
Excised grafts analyzed after a 1-hour exposure to 
physiologic flow showed 64.7% + 2.1% surface cover- 
age for tissue plasminogen activator-transduced ECs 
compared with 73.7% +_ 4.1% for nontransduced ECs 
(p _< 0.05). 
This investigation documented decreased pros- 
thetic graft endothelialization after EC seeding with 
both early- and late-passage lac Z-transduced ECs 
compared with grafts seeded with nontransduced 
ECs. Our in vitro studies demonstrated a etrimental 
effect of lac Z transduction with the BAG retroviral 
vector on EC growth that increased in magnitude 
with cell passage. Limited in vivo graft endothelial- 
ization with lac Z-transduced ECs might reflect an 
increasingly detrimental transduction effect as seeded 
ECs undergo sustained proliferation to complete 
endothelialization f the graft surface. However, 
other factors ingly or in combination with a trans- 
duction effect on proliferation may also contribute to 
decreased invivo endothelialization. Genetic modifi- 
cation of EC linings of synthetic vascular grafts may 
improve their function, but the impact of gene 
transfer on EC function must be studied, if this 
technology is to become clinically relevant. 
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